Guillaume Cartron, MD, PhD

Head of Hematology Department
Centre Hospitalier Universitaire de Montpellier
Montpellier, France

N/A

Presentation(s):

• (1547411) Minimal residual disease-guided combination of ibrutinib and venetoclax compared to FCR in untreated patients with CLL of intermediate risk : interim results of MRD kinetics in the ERADIC trial from the FILO group

  Sunday, October 8, 2023
  9:25 AM – 9:35 AM EDT

• (1550119) Final 7-year Follow Up and Retreatment Substudy Analysis of MURANO: Venetoclax-Rituximab-Treated Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

  Sunday, October 8, 2023
  3:05 PM – 3:10 PM EDT